Clinical Trial Update: Safety Study of Tecadenoson to Treat Atrial Fibrillation [Phase 2]

View source ↗

Summary

Phase 2 safety study of Tecadenoson for atrial fibrillation has completed. The report notes completion of the trial, with no results summarized in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Tecadenoson (tecadenoson)

Snippet

Sponsor: Gilead Sciences | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED